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Glomerular localization of type III collagen in human kidney
disease
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Glomerular localization of type Ill collagen in human kidney disease.
Kidney specimens taken from normal humans and patients with various
renal diseases were examined by immunofluorescent and immunoelec-
tron microscopy using a monoclonal antibody to the a1 chain of type LII
collagen. Indirect immunofluorescent staining revealed that intraglo-
merular localization of type III collagen antigen in 41 of 66 patients,
while it was absent from the glomeruli of normal human kidneys. Type
LII collagen was found within the mesangium of 22 patients with various
types of renal diseases, and was distributed in a focal and segmental
manner in most of the cases. Mesangial localization of the collagen
correlated with the increase in the mesangial matrix. Type HI collagen
was also present in the vascular pole, crescents (particularly in the
organizing phase) and sclerosed glomeruli. Immunoelectron micros-
copy using pre-embedding and post-embedding techniques confirmed
the above observations. These findings indicate that type III collagen
participates in mesangial expansion, crescent organization, and glomer-
ulosclerosis.
Recent biochemical studies on extracellular matrix compo-
nents, and the development of monoclonal antibodies have led
to a better understanding of the constituents of glomerular
basement membrane (GBM) and mesangium in both normal and
diseased human kidneys [1—3]. Type IV collagen, laminin and
proteoglycans are the major components of the glomerular
matrix, and the apparent amounts of these extracellular matri-
ces are frequently increased in the glomeruli in several renal
diseases [3—7]. Progressive glomerulosclerosis, which is a com-
mon histological feature of end-stage kidney disease, is proba-
bly related to the accumulation of the matrix substances [3, 4,
7].
Little is known about the role of interstitial (types I and III)
collagens normally present only in the renal interstitium and
blood vessels. In the present study, the intraglomerular local-
ization of type III collagen was examined in biopsy specimens
from patients with various renal diseases using a monoclonal
antibody recognizing the herical determinant of the collagen
molecule [8].
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Methods
Tissue specimens
Kidney tissues were obtained by percutaneous needle biopsy
or surgical biopsy from 66 patients with renal diseases as shown
in Table 1. Histologically normal portions of kidney tissue
obtained from four patients with renal trauma, renal tumors or
renal calculi were used as normal kidney tissue. For light
microscopic examination, the tissue was fixed in 10% buffered
formalin and embedded in paraffin. Sections of 3 m thick were
stained with hematoxylin eosin, periodic acid-Schiff and methe-
namine silver. Each biopsy specimen was assessed with respect
to the severity of histologic features in the glomeruli (mesangial
cellularity, the increase in mesangial matrix, and the presence
of sclerosis, crescents or adhesion), tubules (atrophy and dila-
tation), interstitium (cell infiltration, edema, and fibrosis), and
arterioles. Abnormalities were then graded semi-quantitatively
(absent or minimal, mild, moderate, or marked) according to
methods previously described by Pirani, Salinas-Madrigal, and
Koss [9].
Reagents
The antibodies used were: mouse monoclonal antibody
against type III collagen (mouse IgG1) [8], affinity-purified
F(ab')2 goat anti-mouse IgG labeled with fluorescein-isothiocy-
anate (FITC) or peroxidase (Cappel, Malvern, Pennsylvania,
USA), and affinity-purified goat anti-mouse IgG conjugated
with biotin (Cappel). The following chemical reagents were
purchased from commercial sources: types I and III collagen
isolated from human placenta (Cosmo Bio Co., Tokyo, Japan),
type II collagen derived from calf articular joint cartilage
(MCK, Tokyo, Japan), type IV collagen purified from EHS
sarcoma (Bethesda Research Laboratories, Gaitherburg, Mas-
sachusetts, USA) or from human placenta (Cosmo Bio Co.),
placental type V collagen (Sigma, St. Louis, Missouri, USA),
affinity purified laminin (E-Y Laboratories, San Mateo, Califor-
nia, USA), human plasma fibronectin (Bethesda Research Lab-
oratories), heparan sulfate isolated from bovine kidney (Sigma),
avidin-peroxidase conjugate (Zymed Laboratories, San Fran-
cisco, California, USA), streptavidin-colloidal gold conjugate
(gold particle size: 20 nm; Bethesda Research Laboratories),
Tween 20 (Sigma), o-phenlylenediamine (Sigma), diaminoben-
zidine HCI (Sigma), trypsin type Ill-S (Sigma), pronase (Kaken
1203
1204 Yoshioka et a!: Type III collagen in glomeru!onephriiis
Table 1. Glomerular localization of type HI collagen in human kidney disease
Disease
No. of
Patients
(+)/total
Localization
mesangiuma
Crescentsa
Hyalinized
glomerulia
Vascular
poled
matrix increaseb (1-)
glomeruli
(%)c(—) (1+) (2+) (3+)
IgA nephropathy 16/32 0/6 6/13 4/4 0.14—0.25 5/li ill 6
Mesangial proliferative
GN without NS 4/9 0/7 1/2 0.40 4
GN with NS 3/3 0/2 1/1 0.50 2
Henoch-Schonlein 5/7 0/1 1/6 0.33 3/4 1/1 1
purpura nephritis
Minimal change NS 2/6 0/3 2/3 0.17, 0.25 0/1 1
Membranous 1/2 0/1 Ill 0.33 0/1
nephropathy
Membranoproliferative
GN 3/5 0/3 2/2 0.25, 0.60 0/1 3
Lupus nephritis 1/4 0/1 0/3 0/I I
Rapidly progressive GN 2/2 0/2 2/2 1/2
Acute poststreptococcal
GN 1/1 1/1 0.33
HUS 1/2 1/2 0.25
Oligomeganephronia 1/1 1/1 0.40
ESRD 1/1 I/I 0.50 1/1
Total 41/66 0/3 3/22 12/34 7/7 10/19 4/7 18
Abbreviations are: GN, glomerulonephritis; NS, nephrotic syndrome; HUS, hemolytic uremic syndrome; ESRD, end-stage renal disease.
a Number of patients demonstrating positive immunofluorescence/number of patients showing mesangial matrix increase, glomerular crescents
or hyalinized glomeruli.b Increase in mesangial matrix was graded as absent or minimal (—), mild (1+), moderate (2+1), or marked (3+).
Proportion of glomeruli positive for type III collagen in the mesangium to total glomeruli examined.d Number of patients showing positive immunofluorescence in the vascular pole.
Pharmaceutical Co., Tokyo, Japan), and collagenase type VII
(Sigma). The purity of the collagens was evaluated by SDS-
polyacrylamide gel electrophoresis using 7.5% gels and found to
be greater than 90%. Type III collagen was free of types IV and
V collagen, laminin and fibronectin contamination by the en-
zyme-linked immunoassay (ELISA) using mouse monoclonal
antibody to type IV collagen (provided by A. F. Michael) [10] or
fibronectin (Bethesda Research Laboratories), and rabbit
monospecific antisera to type V collagen (Advance, Tokyo,
Japan) or laminin (E-Y Laboratories) [7, 11].
SpecfIcity of monoclonal antibody
The reactivity of the monoclonal antibody to type III collagen
was checked by ELISA [12, 13] and immuno-blotting [14].
Avidin-biotin ELISA was performed essentially as described
elsewhere [15]. Microtiter plates were coated overnight with
antigens (0.001 to 10 g/ml of coilagens, laminin, fibronectin
and heparan sulfate) at 4°C, and then incubated serially with the
monoclonal antibody diluted 1:1,000 in phosphate buffered
saline (PBS)/0.05% Tween 20, biotin-conjugated goat anti-
mouse IgG diluted 1:1,000 in PBS/0.05% Tween 20/0.2% bovine
serum albumin (BSA), and avidin-peroxidase diluted 1:1,000 in
PBS/Tween/BSA. Each incubation was performed for one hour
at room temperature. The plate was washed with 0.15 M NaCl/
0.05% Tween 20 between each well change. The reaction with
the substrate solution (o-phenylenediamine/0.03% hydrogen
peroxide) was stopped by the addition of 1 N HC1, and the
absorbance at 490 nm was read, This monoclonal antibody
clearly reacted with type III collagen. There was no or minimal
binding to other types of collagen, laminin, fibronectin or
heparan sulfate at concentrations of up to 10 j.tg/ml.
Samples were applied to 4 to 20% gradient SDS-polyacryl-
amide gels under non-reducing or reducing conditions [16].
After the electrophoretic transfer of peptides from the gels to
nitrocellulose sheets, immunodetection was performed as de-
scribed previously [17]. Briefly, the sheet was preincubated in
3% BSA/50 mM Tris HC1/0. 15 M NaCl (pH 7.4) for one hour at
37°C, and then transferred to the primary antibody solution (1:
100 dilution of monoclonal antibody to type III collagen) for two
hours at room temperature. After washing, goat anti-mouse IgG
labeled with peroxidase (1:200 dilution) was added, and incu-
bated for two hours at room temperature. After washing, the
sheet was developed in the substrate solution, diaminobenzi-
dine HCI/hydrogen peroxide. The monoclonal antibody clearly
bound to the a1 chain of type III collagen (Fig. 1). There was no
reaction with the peptide bands in type I or type IV collagen. A
control experiment using non-immune mouse serum was also
performed.
Immunofluorescence
Indirect immunofluorescence was performed as previously
described [11, 15, 18]. Four m thick sections of kidney
specimens were fixed in cold acetone, incubated with the
monoclonal antibody to type III collagen (1:100 to 500 dilution
in PBS), and then overlaid with normal human plasma preab-
sorbed F(ab')2 goat anti-mouse IgG labeled with FITC (1:32
dilution in PBS). The sections were mounted with p-phenylene-
diamine to retard fluorescence decay [19], and were viewed
Fig. 1. SDS-polyacrylamide gel electrophoresis (4-20% gradient) of
types I, III and IV collagen under reducing conditions. A. Silver
staining. B. Immunoblot reacted with monoclonal antibody to type III
collagen and detected with goat anti-mouse IgG conjugated with per-
oxidase. Lane: a and d, type I collagen; b and e, type III collagen; c and
f: type IV collagen. The monoclonal antibody identified a1 chain of type
III collagen.
under an immunofluorescent microscope (Optiphoto X, Nikon,
Tokyo, Japan), or a phase-contrast immunofluorescent micro-
scope (HF-2, Olympus, Tokyo, Japan). Sections containing at
least four glomeruli were evaluated with respect to the intensity
and location of immunofluorescent staining. In addition, the
percent of positive glomeruli was determined.
As control experiments, normal human kidney sections and
renal tissue sections from some of the patients with renal
diseases were reacted with non-immune mouse serum or unre-
lated IgG mouse monoclonal antibody, DD-3B6/22 [15], fol-
lowed by FITC-goat anti-mouse IgG, or with the secondary
antibody alone.
Immunoelectron microscopy
Pre-embedding method. The indirect peroxidase staining was
performed as reported elsewhere [15]. In brief, the tissue was
fixed in paraform aldehyde-lysine periodate (PLP), and treated
progressively with 10 to 20% sucrose in PBS. Four m thick
sections were incubated with periodate and sodium borohy-
drate to inhibit endogenous peroxidase, and reacted with the
monoclonal antibody to type III collagen (diluted 1:200 to 400)
followed by the peroxidase-labeled F(ab')2 fragment of goat
anti-mouse IgG (preabsorbed with normal human plasma and
diluted 1:10). After being fixed with 10% glutaraldehyde/PBS,
the section was incubated with the substrate solution, diamino-
benzidine/hydrogen peroxide, and post-fixed with osmic acid.
Fig. 2. Indirect immunofluorescent staining with the monoclonal anti-
body to type III collagen in the normal human kidney section. Note that
type III collagen is detected only in the interstitial area. Magnification:
x 400.
Ultrathin sections were observed under an electron microscope
(Hitachi Model HU 12A) without staining by lead citrate.
Control experiments included the incubation of the tissue
section (i) without a primary antibody or (ii) with non-immune
mouse serum or unrelated IgG mouse monoclonal antibody as
the primary antibody.
Post-embedding method. Immunogold staining was per-
formed according to the method described by Horvat et al [20].
Small PLP-fixed pieces of kidney tissues were embedded in the
acrylic resin LR-White (The London Resin Co., Surrey, UK).
The ultrathin sections were mounted on 200-mesh nickel grids,
and serially incubated with the following solutions at room
temperature with PBS washing between each incubation: (i) 1%
BSA in PBS for five minutes, (ii) mouse monoclonal antibody to
type III collagen (diluted 1:400) for 30 minutes, (iii) biotin-
conjugated goat anti-mouse IgG (diluted 1:50) for 20 minutes,
and (iv) streptavidin-colloidal gold conjugate (diluted 1:50) for
30 minutes. After rinsing with distilled water and drying, the
sections were stained with uranyl acetate for five minutes, and
examined under an electron microscope.
The same controls were used as listed above for the pre-
embedding method.
Unmasking experiments
To unmask the antigenic determinants, the tissue sections
were treated with the following buffers or enzymes [18, 21]: 6 M
urealO. 1 M glycine HC1 buffer (pH 3.5), 6 M guanidine HC1/0.05
M Tris HCI buffer (pH 7.4), 100 to 10,000 U/mI of trypsin/0.05 M
Tris HCI-0. 15 M NaC1 (pH 8.0), 10 to 1,000 U/ml of pronase/0.05
M Tris HC1-0.15 M NaCI (pH 8.0), and 10 to 1,000 U/ml of
collagenase/0.05 M Tris HC1-0.2 M NaC1-2 mM CaC12 (pH 7.4).
The sections were incubated with urea buffer for one hour at
4°C [18], and with guanidine buffer for 10 minutes at room
temperature. The sections were allowed to react with each
enzyme for 15 minutes at 37°C. After they were washed in PBS,
the sections were stained with the monoclonal antibody and
FITC-labeled secondary antibody as described above.
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Fig. 3. Immunofluorescence micrographs showing the glomerular localization of type III collagen in the kidney sections of patients with
mesangial proliferative (non-IgA) g!ornerulonephritis (A), membranous nephropathy (B), membranoprolferative glomerulonephritis type II (C),
and IgA nephropathy (D). Note the positive staining along the vascular poles (A and C. arrows), in the mesangium (B and C), and within the
sclerosed glomerulus (D). Magnification (A-D): x 400.
Statistical analysis
The statistical analysis was performed using the Wilcoxon
Rank sum test.
Results
Im,nunofluorescence
The monoclonal antibody to type III collagen clearly reacted
with the renal interstitium and blood vessels of normal human
kidney, but did not bind to any part of the glomerulus or
Bowman's capsule (Fig. 2).
Type III collagen was observed within the glomeruli of 41
patients with renal diseases (Table 1). Regardless of the etiology
of the disease, type III collagen was present in the mesangium,
vascular pole, glomerular crescents, and sclerosed glomeruli
(Figs. 3 and 4). Mesangial type III collagen was found in 22 of
the 41 patients, and showed a focal and segmental distribution
in most of the cases; the collagen was positive in 0.14 to 0.60%
(median, 0.33%) of glomeruli examined on each tissue section,
and generally occupied only small parts of the glomerulus. Two
patients (1 with IgA nephropathy and I with type I membrano-
proliferative glomerulonephritis) with marked mesangial widen-
ing showed a global distribution of the collagen in the mesan-
gium. The staining of type III collagen was weak and segmental
in the cellular crescents, and intense and diffuse in the fibro-
cellular and fibrous crescents. The collagen was unevenly
distributed within the nearly or totally sclerosed glomeruli. The
intensity of the staining for type III collagen in the glomeruli
was generally weaker than that in the renal interstitium.
There was a significant correlation (P = 0.01) between the
presence of type III collagen in the mesangium and the increase
in the mesangial matrix (Table I). The kidney specimens with
moderate or marked interstitial changes tended to show a high
incidence of intraglomerular type III collagen.
Itnmunoelectron microscopy
Kidney tissues from six patients, two patients with IgA
nephropathy, two with Henoch-SchOnlein purpura nephritis
(HSPN), one with stage IV membranous nephropathy (accom-
panied by a moderate increase in mesangial matrix), and one
with type I membranoproliferative glomerulonephritis, were
examined by immunoelectron microscopy. Peroxidase or col-
loidal gold staining for type III collagen was positive in the
mesangium matrix of two patients with IgA nephropathy, one
with membranous nephropathy, and one with membranoproli-
ferative glomerulonephritis, which confirmed the immunofluo-
rescent findings described above (Figs. 5 and 6). In a patient
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Fig. 4. Immunofluorescen: staining for type III collagen in the glomerular crescents of patients with IgA nephropathy (A) and rapidly progressive
glomerulonephritis (B, C and D). The intensity and distribution of staining for type HI collagen (arrows) varied: weak and segmental staining in
a cellular crescent (A), intense and diffuse staining in fibro-cellular (B and C) and fibrous crescents (D). Magnification (A-D): x 400.
with membranoproliferative glomerulonephritis, the collagen
antigen was identified in the circumferential mesangial interpo-
sition. Positive staining for the collagen was observed within
the glomerular crescents and sclerosed glomeruli of two pa-
tients with HSPN (Fig. 7). The collagen fibrils similar to those
stained with peroxidase or colloidal gold in the renal intersti-
tium (Fig. 8), were frequently observed in the crescents and
sclerosed areas. In the mesangial matrix, the fibrillar structure
of the collagen was rarely seen in the loci where gold particles
fixed.
Exposure of tissues to buffers or enzymes
Type III collagen was not detected in the glomeruli of normal
human kidneys or 34 patients with renal disease. Tissue sec-
tions were incubated with 6 M urea (pH 3.5) or 6 M guanidine-
HCI (pH 7.4), or with trypsin, pronase or collagenase, and then
reacted with the monoclonal antibody to the type III collagen.
The staining pattern was not altered by any of these treatments.
Discussion
In the present study, intraglomerular localization of the type
III collagen was examined with a monoclonal probe using the
biopsy specimens from patients with various kidney diseases.
By indirect immunofluorescence, the type III collagen antigen
was observed within the glomeruli of 41 of the 66 patients
studied, while it was completely absent from the glomeruli of
normal human kidneys. Regardless of the etiology of the
disease, the collagen was localized in the mesangium of 22 of
the 41 patients. The mesangial type III collagen was observed
generally in a focal and segmental pattern, and correlated well
with the increase in the mesangial matrix. The collagen was also
found in the vascular poles, crescents and sclerosed glomeruli.
Less is known about the glomerular localization and the role
of interstitial collagens in kidney disease, although there are
several reports on the distribution of the collagens in normal
human and animal kidneys [3, 22—241. In the normal kidney,
type III collagen is present in the interstitium and blood vessels,
but not in any structures of the glomeruli. Using immunofluo-
rescent staining, Striker and coworkers [31 first described the
localization of type III collagen in the glomeruli of patients with
renal dsease; the collagen was present in the large synechiae in
focal sclerosis, in the fibrous crescents in anti-glomerular base-
ment membrane nephritis and in all stages of crescents associ-
ated with vasculitis, The present study shows that the type III
collagen antigen is widely distributed in the glomeruli of pa-
tients with kidney disease; besides glomerular crescents, type
III collagen was detected in the mesangium, vascular poles, and
sclerosed areas.
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Fig. 5. Immunoelectron microscopy of a portion of a glomerulus in a patient with IgA nephropathy with immunogold staining for type Ill
collagen. At low magnification (A) and higher magnification (B, the portion designated by an arrow in A), the gold particles are seen to be
distributed in the mesangial matrix. CL: glomerular capillary lumen, MC: mesangial cell, MM: mesangial matrix. Magnification: A, x 4000; B, x
8000.
Fig. 6. Immunoelectron microscopy of a portion of a glomerulus in a patient with membranoproliferative glomerulonephritis type I, stained with
indirect peroxidase for type III collagen. Note the reaction products in the mesangial area. CL: capillary lumen, MC: mesangial cell. Magnification:
x 5000.
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Fig. 7. Ultrastructural observation of type I!! collagen in the glomerular crescent in a patient with Henoch-SchOnlein purpura nephritis, stained
with peroxidase. The reaction products are seen to be distributed between the crescentic cells. BC: basement membrane of Bowman's capsule,
CR: crescent, I: interstitium. Magnification: x 3000.
Mesangial localization of type III collagen was confirmed by
immunoelectron microscopic studies in IgA nephropathy, mem-
branous nephropathy and membranoproliferative glomerulone-
phritis. Circumferential mesangial interposition found in a pa-
tient with type I membranoproliferative glomerulonephritis also
contained the type III collagen antigen. These observations
suggest that the type III collagen contributes to the mesangial
expansion. Using immunoperoxidase and immunogold staining,
we found the fibrillar structure of type III collagen, which was
in agreement with the previous observation by Fleischmajer
and coworkers [251. The structure was evident in the renal
interstitjum, crescents and scierosed glomeruli, but was rarely
found in the mesangium, suggesting low amounts or incom-
pletely processed molecules of the collagen in the mesangium of
the diseased kidneys. Timple, Wick and Gay [26] reported
positive immunofluorescent staining for type III collagen lo-
cated frequently in amorphous regions of various connective
tissues.
The precise mechanism for the appearance of type III colla-
gen within the glomeruli of kidney disease is unknown. Our
findings suggest at least three possibilities: (1) synthesis by
mesangial cells, (ii) infiltration from the interstitium, and (iii)
vascular origin. The first possibility is supported by in vitro
studies with the use of glomerular cell cultures, which found
that mesangial cells isolated from normal kidneys can synthe-
size interstitial (types I and III) collagen as well as basement
membrane (types IV and V) collagen, fibronectin and proteo-
glycans [27, 28]. The production of type III collagen by mesan-
gial cells is normally repressed in vivo, because the collagen is
absent from normal glomeruli. Substantial evidence [29] indi-
cates that the expression of genes for different collagen types is
modulated by various conditions. For example, the synthesis of
type II collagen by chondroblasts is sensitive to cell density,
Ca2, pyrophosphate, cyclic AMP and calcitonin, and type IV
collagen production by mouse embryonic carcinoma cells is
influenced by retinoic acid and cell density. A switch from type
II to type I collagen synthesis, or from type IV to type I has
been observed [29]. Some stimuli released in the pathologic
states in vivo or in the culture conditions could lead the
mesangial cells to synthesize the collagen.
The second mechanism, infiltration of type III collagen from
the interstitium, is highly likely, particularly in the case of
crescents and sclerosed glomeruli. The immunofluorescent
staining for type III collagen was continuously distributed from
the crescent to the adjacent interstitium, and the morphology at
the ultrastructural level was similar to that found in the inter-
stitium. Striker et al [3] also raised this possibility, because they
found that type III collagen in the crescents is continuous to the
interstitium, and is closely associated with the disruption of
Bowman's capsule. Our previous observation suggested that
parietal epithelial cells of the glomerulus play a dominant role in
the early stage of crescent formation, and that the accumulation
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Fig. 8. Localization of type Ill collagen in the renal interstitium of a patient with membranoprolferative glomeru!onephritis (type I) by
post-embedding technique. Thin fibrils are stained with gold particles. BC: Bowman's capsule, I: interstitium, TC: tubular epithelial cell, TBM:
tubular basement membrane. Magnification: A X 6000.
of intrinsic basement membrane components is correlated with
the progression of the crescents [11]. Epithelial cells have not
been shown to synthesize type III collagen [30]. Therefore, it is
tempting to assume that interstitial cells, principally fibroblasts,
migrate through the disrupted Bowman's capsule into the
glomeruli, and secrete type III collagen, contributing to the
crescent organization and glomerulosclerosis.
Type III collagen observed in a circular or semi-circular form
along the vascular pole might be of vascular origin, because
smooth muscle cells in blood vessel walls can produce type III
collagen [27, 30]. The possibility that type III collagen in the
vascular poles is that expanded from the mesangial areas, and
vice versa still remains to be confirmed, because cells of the
afferent arterioles are morphologically associated with the
glomerular mesangium through the juxtaglomerular apparatus
[31].
It is now known that some antigenic determinants in the renal
tissues are masked by their interaction with other components,
and are unmasked after the treatment with acid-urea buffer [18].
To examine this possibility, tissue sections were incubated with
different enzymes and buffer solutions. None of these treat-
ments were able to disclose type III collagen antigen determi-
nants in normal glomeruli, indicating that the expression of type
III collagen in the mesangium occurs exclusively after glomer-
ular injury.
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